Elevance Health Free Cash Flow 2010-2024 | ELV
Elevance Health annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Elevance Health free cash flow for the quarter ending September 30, 2024 was 4,168.00, a year-over-year.
- Elevance Health free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.
- Elevance Health annual free cash flow for 2023 was $6.765B, a 6.65% decline from 2022.
- Elevance Health annual free cash flow for 2022 was $7.247B, a 0.41% decline from 2021.
- Elevance Health annual free cash flow for 2021 was $7.277B, a 24.72% decline from 2020.
| Elevance Health Annual Free Cash Flow | |
|---|---|
| 2023 | 6,765.00 |
| 2022 | 7,247.00 |
| 2021 | 7,277.00 |
| 2020 | 9,667.00 |
| 2019 | 4,984.00 |
| 2018 | 2,619.00 |
| 2017 | 3,394.00 |
| 2016 | 2,686.00 |
| 2015 | 3,609.00 |
| 2014 | 2,742.70 |
| 2013 | 2,445.00 |
| 2012 | 2,200.10 |
| 2011 | 2,858.60 |
| 2010 | 966.10 |
| 2009 | 2,660.90 |
| Elevance Health Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | 4,168.00 |
| 2024-06-30 | 1,823.00 |
| 2024-03-31 | 1,699.00 |
| 2023-12-31 | 6,765.00 |
| 2023-09-30 | 10,062.00 |
| 2023-06-30 | 7,768.00 |
| 2023-03-31 | 6,168.00 |
| 2022-12-31 | 7,247.00 |
| 2022-09-30 | 9,063.00 |
| 2022-06-30 | 4,444.00 |
| 2022-03-31 | 2,287.00 |
| 2021-12-31 | 7,277.00 |
| 2021-09-30 | 5,945.00 |
| 2021-06-30 | 3,699.00 |
| 2021-03-31 | 2,301.00 |
| 2020-12-31 | 9,667.00 |
| 2020-09-30 | 6,132.00 |
| 2020-06-30 | 7,588.00 |
| 2020-03-31 | 2,311.00 |
| 2019-12-31 | 4,984.00 |
| 2019-09-30 | 4,008.00 |
| 2019-06-30 | 2,612.00 |
| 2019-03-31 | 1,396.00 |
| 2018-12-31 | 2,619.00 |
| 2018-09-30 | 2,476.00 |
| 2018-06-30 | 2,224.00 |
| 2018-03-31 | 1,997.00 |
| 2017-12-31 | 3,394.00 |
| 2017-09-30 | 4,973.00 |
| 2017-06-30 | 2,787.10 |
| 2017-03-31 | 2,560.30 |
| 2016-12-31 | 2,686.00 |
| 2016-09-30 | 2,577.80 |
| 2016-06-30 | 1,778.20 |
| 2016-03-31 | 1,242.30 |
| 2015-12-31 | 3,609.00 |
| 2015-09-30 | 2,793.90 |
| 2015-06-30 | 2,593.80 |
| 2015-03-31 | 1,561.70 |
| 2014-12-31 | 2,742.70 |
| 2014-09-30 | 2,653.60 |
| 2014-06-30 | 2,187.30 |
| 2014-03-31 | 1,251.80 |
| 2013-12-31 | 2,445.00 |
| 2013-09-30 | 2,371.40 |
| 2013-06-30 | 1,132.60 |
| 2013-03-31 | 849.40 |
| 2012-12-31 | 2,200.10 |
| 2012-09-30 | 1,610.10 |
| 2012-06-30 | 1,518.90 |
| 2012-03-31 | 1,099.30 |
| 2011-12-31 | 2,858.60 |
| 2011-09-30 | 2,983.40 |
| 2011-06-30 | 1,683.10 |
| 2011-03-31 | 1,013.00 |
| 2010-12-31 | 966.10 |
| 2010-09-30 | 502.10 |
| 2010-06-30 | -284.20 |
| 2010-03-31 | -440.00 |
| 2009-12-31 | 2,660.90 |
| 2009-09-30 | 2,737.30 |
| 2009-06-30 | 1,412.10 |
| 2009-03-31 | 1,123.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $96.018B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $46.162B | 17.64 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| ICON (ICLR) | Ireland | $18.182B | 16.19 |
| Natera (NTRA) | United States | $15.356B | 0.00 |
| Avantor (AVTR) | United States | $15.184B | 22.76 |
| Revvity (RVTY) | United States | $14.929B | 26.14 |
| Viatris (VTRS) | United States | $13.870B | 4.23 |
| BioMerieux (BMXMF) | France | $12.753B | 0.00 |
| Solventum (SOLV) | United States | $12.515B | 0.00 |
| CochLear (CHEOY) | Australia | $12.315B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.932B | 27.98 |
| Charles River Laboratories (CRL) | United States | $9.343B | 17.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.376B | 0.00 |
| Doximity (DOCS) | United States | $7.863B | 49.82 |
| HealthEquity (HQY) | United States | $7.539B | 40.92 |
| Bausch + Lomb (BLCO) | Canada | $7.221B | 33.62 |
| PACS (PACS) | United States | $6.544B | 0.00 |
| Life Times (LTH) | United States | $4.665B | 30.88 |
| Organon (OGN) | United States | $4.653B | 4.69 |
| Sotera Health (SHC) | United States | $4.492B | 22.66 |
| Surgery Partners (SGRY) | United States | $3.655B | 40.49 |
| BrightSpring Health Services (BTSG) | United States | $2.958B | 63.89 |
| Concentras Parent (CON) | United States | $2.542B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.527B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.482B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.349B | 88.43 |
| GeneDx Holdings (WGS) | United States | $2.094B | 0.00 |
| Premier (PINC) | United States | $2.032B | 9.14 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.402B | 7.04 |
| Progyny (PGNY) | United States | $1.354B | 23.81 |
| Pediatrix Medical (MD) | United States | $1.306B | 12.78 |
| Establishment Labs Holdings (ESTA) | $1.269B | 0.00 | |
| CareDx (CDNA) | United States | $1.194B | 0.00 |
| Agilon Health (AGL) | United States | $1.111B | 0.00 |
| Embecta (EMBC) | United States | $0.822B | 5.48 |
| InnovAge Holding (INNV) | United States | $0.803B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.707B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| DocGo (DCGO) | United States | $0.371B | 13.96 |
| Enhabit (EHAB) | United States | $0.365B | 31.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.325B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| ModivCare (MODV) | United States | $0.230B | 7.32 |
| Beauty Health (SKIN) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.114B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.53 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |